Cart summary

You have no items in your shopping cart.

Acipimox

SKU: orb1224877

Description

Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. Long-term administration is associated with reduced mortality, but unwanted effects limit its clinical use. (In Vitro):Acipimox (0-100 μM; 0-4 hours) enhances leptin release from adipocytes isolated from Sprague-Dawley rats in a time- and dose- dependent manner.Acipimox (10 mM) stimulats leptin release in adipocytes from Streptozotocin (STZ)-treated and Zucker diabetic fat (ZDF) rats.(In Vivo):Acipimox (50 mg/kg; i.p.) significantly lowers circulating free fatty acid (FFA) and glucose in high-fat fed mice.

Images & Validation

Key Properties

CAS Number51037-30-0
MW154.13
Purity>98% (HPLC)
FormulaC6H6N2O3
SMILESO=C(C1=C[N+]([O-])=C(C)C=N1)O
Targettriglycerides production
SolubilityDMSO: 31 mg/mL (201.14 mM)

Bioactivity

In Vivo
Acipimox (50 mg/kg; i.p.) significantly lowers circulating free fatty acid (FFA) and glucose in high-fat fed mice. Animal model: Female C57BL/6J mice. Dosage: 50 mg/kg. Administration: Intraperitoneal injection. Result: Reduced circulating levels of FFA and glucose after 3 h.
In Vitro
Acipimox (0-100 μM; 0-4 hours) enhances leptin release from adipocytes isolated from Sprague-Dawley rats in a time- and dose- dependent manner. Acipimox (10 mM) stimulats leptin release in adipocytes from Streptozotocin (STZ)-treated and Zucker diabetic fat (ZDF) rats.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Acipimox | K-9321 | K9321 | K 9321 | Olbemox | Olbetam

Similar Products

  • Acipimox [orb1309554]

    99.26% (May vary between batches)

    51037-30-0

    154.12

    C6H6N2O3

    25 mg, 100 mg, 500 mg, 50 mg
  • Acipimox sodium [orb1744695]

    76958-97-9

    176.11

    C6H5N2NaO3

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Acipimox (orb1224877)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
25 mg
$ 90.00
50 mg
$ 120.00
100 mg
$ 160.00
200 mg
$ 220.00